This inventor holds 2 USPTO granted patents. Top assignee: Genentech, Inc.. Active years: 2002-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2006
Title: Suzanne Sin-Mui Lo Weck: Innovator in Pharmaceutical Solutions
Introduction
Suzanne Sin-Mui Lo Weck is a prominent inventor based in Mountain View, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid solutions for DNase. Her innovative work has led to the filing of multiple patents, showcasing her expertise and dedication to advancing medical science.
Latest Patents
Suzanne holds 2 patents related to DNase liquid solutions. Her first patent focuses on the use of calcium ion and/or sugars to minimize thermal aggregation of DNase. This invention also emphasizes the stabilization of liquid solutions of DNase at a pH of less than neutral. The solutions are designed to be suitable for pharmaceutical administration, containing other pharmaceutically acceptable excipients. The second patent similarly addresses the minimization of thermally induced aggregation of DNase in solution with calcium, reinforcing the importance of calcium ion in stabilizing lower pH solutions from protein precipitation.
Career Highlights
Suzanne is currently associated with Genentech, Inc., where she continues to innovate in the pharmaceutical sector. Her work has not only contributed to the scientific community but has also paved the way for advancements in drug formulation and delivery.
Collaborations
Throughout her career, Suzanne has collaborated with notable colleagues, including Hak-Kim Chan and Igor Gonda. These partnerships have further enriched her research and development efforts.
Conclusion
Suzanne Sin-Mui Lo Weck is a trailblazer in the field of pharmaceutical innovations, particularly in the development of DNase solutions. Her contributions are vital to the ongoing advancements in medical treatments and drug formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
